Cosmos Health Inc. (NASDAQ:COSM) Sees Large Growth in Short Interest

Cosmos Health Inc. (NASDAQ:COSM) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 2,343,632 shares, an increase of 163.2% from the May 31st total of 890,287 shares. Approximately 5.1% of the shares of the company are short sold. Based on an average daily volume of 14,830,375 shares, the short-interest ratio is currently 0.2 days.

Cosmos Health Stock Performance

COSM opened at $0.17 on Monday. The company has a current ratio of 1.08, a quick ratio of 0.92 and a debt-to-equity ratio of 0.31. The business’s 50 day moving average is $0.28 and its 200-day moving average is $0.37. The stock has a market cap of $10.69 million, a PE ratio of -0.27 and a beta of 4.80. Cosmos Health has a twelve month low of $0.16 and a twelve month high of $1.32.

Cosmos Health (NASDAQ:COSM) last posted its earnings results on Thursday, May 21st. The company reported ($0.06) EPS for the quarter, meeting the consensus estimate of ($0.06). The firm had revenue of $18.40 million for the quarter, compared to analysts’ expectations of $17.93 million. Cosmos Health had a negative return on equity of 52.85% and a negative net margin of 30.41%. On average, analysts predict that Cosmos Health will post -0.06 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Cosmos Health in a report on Monday, June 15th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Cosmos Health presently has a consensus rating of “Sell”.

Insider Activity at Cosmos Health

In related news, CEO Grigorios Siokas acquired 218,447 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was purchased at an average cost of $0.21 per share, for a total transaction of $45,873.87. Following the purchase, the chief executive officer directly owned 13,481,808 shares in the company, valued at $2,831,179.68. This represents a 1.65% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Georgios Terzis bought 168,135 shares of the company’s stock in a transaction on Tuesday, June 16th. The stock was bought at an average cost of $0.25 per share, for a total transaction of $42,033.75. Following the completion of the transaction, the chief financial officer directly owned 2,235,398 shares of the company’s stock, valued at $558,849.50. This trade represents a 8.13% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders purchased 1,088,029 shares of company stock worth $249,240. Company insiders own 26.15% of the company’s stock.

Hedge Funds Weigh In On Cosmos Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC lifted its holdings in shares of Cosmos Health by 16.7% in the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock valued at $124,000 after buying an additional 55,925 shares during the period. Citadel Advisors LLC grew its holdings in Cosmos Health by 133.1% during the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after acquiring an additional 128,776 shares during the period. Finally, XTX Topco Ltd raised its position in Cosmos Health by 52.1% in the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after acquiring an additional 34,117 shares in the last quarter. 12.61% of the stock is owned by institutional investors.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.